Danaher to Acquire Nobel Biocare for $2.2B in Cash
Science and technology giant Danaher has agreed to acquire Nobel Biocare Holding in an all cash deal valued at approximately $2.2 billion. The move will expand Danaher’s foothold in the global dental industry and allow Nobel Biocare to accelerate strategic objectives and future growth, Danaher says.
Headquartered in Zurich, Switzerland, Nobel Biocare is a market leader in the production of implant-based dental restorations. The company’s portfolio includes dental implant systems, high-precision individualized prosthetics, biomaterials and digital diagnostics, treatment planning and guided surgery.
Washington D.C.-based Danaher values its dental segment at $2.2 billion. The addition of Nobel Biocare will complement Danaher’s position in the implant industry, the company says.
“Bringing Nobel Biocare's deep expertise in implant dentistry, digital prosthetics and software together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize clinical workflows to the benefit of patients and dental practitioners,” says Henk van Duijnhoven, Dsenior vice president of Danaher’s dental segment.
The offer is expected to be completed in late 2014 or early 2015. — Kellen Owings
Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.